AGN Financial Facts
Diluted (in dollars per share): 0.04Interest income: 1.6M
See Full Income Statement
Total current assets: 4.07B
Trade receivables, net: 887.9M
See Full Balance Sheet
Earnings History for Allergan Inc. (AGN)
|
Expand Research on AGN
| Next EPS Date | 7/31/13 *Est. | EPS Growth Rate | +14.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +0.2% | Revenue Growth Rate | +106,469.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -0.5% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/13  |
 |
Q113 | $0.98 | $0.96 | +$0.02 | $1.46B | $1.44B | N/A / N/A | = | -13.7% | Details |
| 2/5/13 |
|
Q412 | $1.15 | $1.20 | -$0.05 | $1.48M | $1.51M | N/A / N/A | = | -6.7% | Details |
| 10/30/12 | Q312 | $1.06 | $1.04 | +$0.02 | $1.39B | $1.43B | $1.04 / $1.42B | = | +7% | Details | |
| 8/1/12 |
|
Q212 | $1.07 | $1.06 | +$0.01 | $1.47B | $1.5B | N/A / N/A | = | +19.4% | Details |
| 5/2/12 |
|
Q112 | $0.86 | $0.87 | -$0.01 | $1.37M | $1.38M | N/A / N/A | = | +1.7% | Details |
| 2/2/12 |
|
Q411 | $1.00 | $1.00 | $0.00 | $1.38B | $1.41B | N/A / N/A | = | +12.3% | Details |
| 10/26/11 |
|
Q311 | $0.92 | $0.90 | +$0.02 | $1.31B | $1.33B | N/A / N/A | = | +12.7% | Details |
| 8/3/11 |
|
Q211 | $0.96 | $0.95 | +$0.01 | $1.4B | $1.34B | N/A / N/A | = | +26.7% | Details |
